The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
But nonetheless, I think in the years to come, we are going to see a lot more of L-tyrosine, PEA phenethylamine and huperzine as a way of tapping into the dopaminergic and cholinergic circuits certainly along with things like Alpha-GPC as non-prescription, short-lived somewhat milder alternatives to things that really spike dopamine, things like Adderall, Ritalin, modafinil, armodafinil and similar.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.